loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 21134 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 VIATRIS (3)

filter

01 TABLET;SUBLINGUAL (3)

filter

01 RX (3)

filter

01 NITROSTAT (3)

filter

01 Yes (3)

URL Supplier Web Content
TABLET; SUBLINGUAL
0.3MG
2000-05-01
21134
NITROSTAT
RX
Yes
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET; SUBLINGUAL
0.4MG
2000-05-01
21134
NITROSTAT
RX
Yes
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET; SUBLINGUAL
0.6MG
2000-05-01
21134
NITROSTAT
RX
Yes
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 21134

Looking for FDA Orange Book APPLICATION 21134 3

19

Viatris, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is NITROGLYCERIN, with a corresponding application number 21134.

Regulatory Information RX

With a dosage strength 0.3MG

Dosage Form Route TABLET; SUBLINGUAL

Reference Listed Drug Yes

Approved since 2000-05-01

Therapeutic Equivalence (TE) Code AB

18

Viatris, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is NITROGLYCERIN, with a corresponding application number 21134.

Regulatory Information RX

With a dosage strength 0.4MG

Dosage Form Route TABLET; SUBLINGUAL

Reference Listed Drug Yes

Approved since 2000-05-01

Therapeutic Equivalence (TE) Code AB

17

Viatris, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is NITROGLYCERIN, with a corresponding application number 21134.

Regulatory Information RX

With a dosage strength 0.6MG

Dosage Form Route TABLET; SUBLINGUAL

Reference Listed Drug Yes

Approved since 2000-05-01

Therapeutic Equivalence (TE) Code AB

Post Enquiry
POST ENQUIRY